-transparent.png){kind=logo}
Seventeen recently established human breast carcinoma cell lines of metastatic origin (MDA series), HeLa cells, and MCF-7 (a well-established breast carcinoma cell line) were studied by starch gel electrophoresis for allozymic differences at 17 enzyme loci. Ten loci proved to be informative in establishing unique genetic signatures for all of the lines with the exception of MDA-134 and -309, which had the same genetic signatures. The probability of these latter two lines being of independent origin and finding their similar genetic signatures by chance is 0.07. These studies enable us to conclude that the chromosomal marker shown to be common to these breast carcinoma cell lines of metastatic origin is not present because of cross-contamination of the lines with other long-term lines or each other.
M J Siciliano, and
P E Barker, and
R Cailleau
September 2013,
Genes & development,
M J Siciliano, and
P E Barker, and
R Cailleau
January 1962,
Medical bulletin (Ann Arbor, Mich.),
M J Siciliano, and
P E Barker, and
R Cailleau
July 1975,
International journal of cancer,
M J Siciliano, and
P E Barker, and
R Cailleau
December 2017,
Molecular systems biology,
M J Siciliano, and
P E Barker, and
R Cailleau
August 2016,
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference,
M J Siciliano, and
P E Barker, and
R Cailleau
February 2000,
Oncogene,
M J Siciliano, and
P E Barker, and
R Cailleau
March 2021,
Oncotarget,
M J Siciliano, and
P E Barker, and
R Cailleau
August 2005,
Oncogene,
M J Siciliano, and
P E Barker, and
R Cailleau
December 2009,
Cancer cell,
M J Siciliano, and
P E Barker, and
R Cailleau
March 2006,
Breast cancer research and treatment,
